Cellular Dynamics International is following a split with a spinoff.
The leaves soak up the early fall sun and we wrap up another busy news week. We’re reviewing big artificial intelligence announcements from Microsoft and its chief competitors; more funding for Remitly; a conversational competition from Amazon; a milestone launch for... Read more »
Arrowhead Pharmaceuticals and Amgen will together work to develop and commercialize two drugs designed to treat cardiovascular disease, the companies said Thursday.
Under the terms of the agreements, Amgen will pay Arrowhead a combined $56.5 million—$35 million in cash, and the... Read more »
Startup creation firm Allied Minds announced a partnership Thursday with GE’s venture arm to jointly invest in promising technologies.
The deal speaks to broader trends in how companies get formed and funded beyond traditional means like venture capital and the public... Read more »
With public interest in artificial intelligence technologies on the rise, five of the world’s largest corporations—vying against each other in so many spheres—are banding together to support research on the ethical and societal issues raised by machines with increasingly human-like capabilities.... Read more »
[Updated 9/29/16, see below] Several promising antipsychotic drugs have made it to late-stage clinical trials only to come up short. Today, you can add an experimental treatment from Intra-Cellular Therapies to the list.
Shares of New York-based Intra-Cellular (NASDAQ:... Read more »
Janet Woodcock, the top drug evaluator at the FDA, was the driving force behind the FDA’s recent decision to approve eteplirsen (Exondys 51), a drug for patients with Duchenne muscular dystrophy from Cambridge, MA-based Sarepta Pharmaceuticals (NASDAQ: SRPT).
The decision... Read more »
Smart-home technology has gone to the dogs.
New York-based Entrepreneurs Roundtable Accelerator (ERA) graduated 12 startups today, including Dog Parker—a connected doghouse that minds people’s pets while they shop at stores.
That is one example of the broad array of... Read more »
Earlier this year, Xconomy compiled a list and map of cybersecurity organizations in the Boston area and found 60-plus companies. One that we missed was Avecto, a U.K.-based endpoint security software firm that opened a Massachusetts outpost in 2009, a... Read more »
Managing Partner at Pappas Ventures
Chairman and CEO, Nanobiosym Diagnostics Inc.
Founder and CEO of Brooks Bell Inc.
CEO of Project Foundry
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute